CDKN1A and central nervous system cancer: At the molecular level, one report showed that MET/EGFR signaling is regulated by FAM83H-AS1, and16 showed that FAM83H‐AS1 epigenetically silenced CDKN1A by binding to EZH2 in glioma cells.